Close
A ‘wee molecule’: the tiny urinary biomarker neopterin and its role in MND progression

A ‘wee molecule’: the tiny urinary biomarker neopterin and its role in MND progression

Reading Time: 6 minutes My name is Stephanie Shepheard, and I am a Research Associate in the Motor Neuron Disease & Neurotrophic Research Laboratory (MND&NR Lab), Flinders Health & Medicine Research Institute in the College of Medicine & Public Health at Flinders University, South Australia. I measure biological changes, or biomarkers, that may tell us something useful about motor…

What a difference a year makes: on entering the ALS research community 

What a difference a year makes: on entering the ALS research community 

Reading Time: 5 minutes This is a guest blog written by Danielle Boyce, DPA, MPH, Executive Director, the Robert Packard Center for ALS Research and Answer ALS Research Program; Assistant Professor, Johns Hopkins School of Medicine, Division of Neurology  If 2021 taught me anything, it is the difference that one year can make in the fight against motor neuron…

New discovery reveals why mysterious genetic variant impacts ALS severity

New discovery reveals why mysterious genetic variant impacts ALS severity

Reading Time: 4 minutes My name is Oscar Wilkins and I am a PhD student working with Professors Pietro Fratta (recipient of a MND Association Research Fellowship) and Jernej Ule. Recently, in collaboration with Sarah Hill and Michael Ward, a team led by PhD student Anna-Leigh Brown, postdoctoral researcher Matt Keuss and myself uncovered a promising new target for…

Celebrating Peer Review

Celebrating Peer Review

Reading Time: 4 minutes This week marks global Peer Review Week and we are joining the international science community in celebrating the role that peer reviewers play in the research world. What is peer review and why is it so important? Peer review involves the evaluation and assessment of scientific or academic work by those working in the same…

Translational research in MND: Our partnership with LifeArc

Translational research in MND: Our partnership with LifeArc

Reading Time: 4 minutes Translational Research is the term used to describe studies that are the bridge between fundamental laboratory-based research and the testing of potential therapies (often by pharmaceutical companies) in the clinic. Without the continued journey of research concepts and ideas from all research and development stages from ‘bench to bedside’ it is almost impossible to develop…

Connecting Patient Data and Artificial Intelligence to Advance MND Research

Connecting Patient Data and Artificial Intelligence to Advance MND Research

Reading Time: 5 minutes “The search for new drugs to help MND patients is a long and challenging one, but it is one where we are beginning to see hope for the future emerging on several fronts. New Artificial Intelligence (AI) data analysis techniques and larger, more detailed collections of patient data have been pivotal in these advances.” Dr…

Spotlight on the ‘International’ Symposium experience

Spotlight on the ‘International’ Symposium experience

Reading Time: 4 minutes We recently announced that following the success of our first virtual International Symposium on ALS/MND (the largest medical and scientific conference specific to MND/ALS) last year and the ongoing challenges caused by the global pandemic, the MND Association’s 32nd Symposium in December 2021 will be held online. As we head towards our Symposium this year,…